There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Tasquinimod is an orally active anticancer drug in late clinical development. Here
we describe the development and validation of a bioanalytical method based upon dried
blood spot analysis in combination with LCMS/MS and stable isotope dilution.